pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›Doxycycline Prasco
drug
save

doxycycline ER

Marketedupdated 4mo ago
by Prasco LLC
Approved
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval340 co-mentions · 170 sources
  • drugDOXYCYCLINE173 co-mentions · 173 sources
  • drugVibramycin173 co-mentions · 173 sources
  • drugDrug for Unspecified Dermatological Disorders173 co-mentions · 173 sources
  • tagSmall Molecule168 co-mentions · 168 sources
  • drugdoxycycline hyclate CR109 co-mentions · 109 sources
  • drugDoryx109 co-mentions · 109 sources
  • drugdoxycycline hyclate DR109 co-mentions · 109 sources

all catalysts(39)

approval · 38
Dec 1, 2000
approval
26y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 15, 2000
approval
26y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Oct 17, 2001
approval
25y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Feb 26, 2002
approval
25y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 19, 2002
approval
24y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 30, 2002
approval
24y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 30, 2002
approval
24y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
May 21, 2003
approval
23y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Feb 20, 2004
approval
23y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Mar 26, 2004
approval
22y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Apr 15, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Apr 18, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Apr 18, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Jul 14, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Jul 14, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Jul 15, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 1, 2005
approval
21y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Mar 12, 2009
approval
17y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Mar 12, 2009
approval
17y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Apr 18, 2012
approval
14y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 14, 2012
approval
14y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
May 31, 2013
approval
13y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Jul 10, 2014
approval
12y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Sep 26, 2014
approval
12y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 20, 2015
approval
11y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Dec 20, 2015
approval
11y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Sep 23, 2016
approval
10y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Oct 30, 2017
approval
9y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 30, 2022
approval
4y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 30, 2022
approval
4y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
2y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
2y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
2y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
2y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Aug 26, 2024
approval
2y ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Oct 1, 2025
approval
11mo ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Mar 11, 2026
approval
6mo ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
Mar 20, 2026
approval
6mo ago
DOXYCYCLINE — FDA approval
doxycycline ER
→
phase 2 completion · 1
Apr 30, 2026
phase 2 completion
4mo ago
University of Benin Teaching Hospital — doxycycline (Phase II Trial Completion)
doxycycline ER
→
view all 39 catalysts →

Trials studying doxycycline ER

  • phase2Isotretinoin vs. Doxycycline for Acneiform Rash in Patients Receiving Drugs That Target the MAPK Pathwaynot yet recruitingn=50
  • phase2Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinibactive not recruitingn=305
  • —Pharmacokinetics and Safety of Commonly Used Drugs in Lactating Women and Breastfed Infantsrecruitingn=1,600
  • phase4Comparing Sarecycline and Doxycycline Effects on the Skin and Gut Bacteria in Acne.recruitingn=30
  • phase1Pembrolizumab With Intratumoral Injection of Clostridium Novyi-NTactive not recruitingn=18
  • phase2Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trialnot yet recruitingn=300
  • phase2Velocity 2: An Anthrax Vaccine and Antibiotics Clinical Studycompletedn=210
  • phase3A Randomized, Double-Blind Study to Assess the Safety, Efficacy and Tolerability of Oral DFD-29 Capsules for the Treatment of Rosacea.completedn=323
more trials →

Patent cliff

source: FDA Orange Book
first barrier falls
Dec 19, 2027
~1.3 years out

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (1)

  • Dec 19, 2027formulationUS 77495321.3y

News(1)

  • Syphilis spreads while researchers contend with federal constraints and a drug shortage
    At the San Diego-Tijuana border, syphilis spreads while researchers contend with federal constraints and a drug shortage.
    stat · 1mo ago
brand
Doxycycline Prasco
generic
doxycycline
indication
Rosacea
phase
marketed
Data sources
openFDA · ClinicalTrials.gov
last refreshed 2h ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?